BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Thales Nanotechnology, Inc. Opens Own Representation in the United Kingdom and has New Distribution Agreements for Europe and India


9/24/2007 7:44:10 AM

BUDAPEST, Hungary, September 24 /PRNewswire/ -- ThalesNano Inc., a leading developer and manufacturer of flow chemistry, flow reactor technology, and hydrogenation technology solutions, announced today that it had continued to expand globally by opening a subsidiary in the United Kingdom and by signing distributor agreements in Scandinavia, Italy, and India.

Building its own subsidiary reflects ThalesNano's commitment to bridging closer ties with its customers and expanding operations globally; it is intended to enhance activities in particular towards the chemical and pharmaceutical sectors, and to reinforce visibility. The UK representatives will bring both added value in operational terms and flexibility for customers.

Alex Drijver, CFO commented: "Chemists will have a local point of contact for advice on the most up-to-date chemistry technologies and solutions. ThalesNano Inc. was already operating successfully through a distributor company in the UK and can now strengthen and consolidate its position with help of its local team of professionals. The UK is a strategic market for the company's growth, as the country's R&D spending is the largest within Europe and has the most developed and innovative pharmaceutical and chemical industry. In this way, ThalesNano Inc. can effectively support UK customers at all times with the necessary technology knowledge."

The new UK ThalesNano team replaces former distributor Asynt Inc., with whom the company's contract expired in September. The Danish distributor company, Biolab A/S is taking over customers from Asynt Inc. in the Scandinavian region. While in Italy, Stepbio S.R.L. is the new distributor of ThalesNano products.

As a result of ThalesNano's global expansion, and as a response to the demand for its products and technologies from India, the company has started its operation through cooperation with Inkarp Instruments Pvt. Ltd.

Dr. Ferenc Darvas, president and chairman commented: "The development and growth of both ThalesNano's sales team and the distributor network comes two years after the initial launch of the award winning H-Cube(R), which is rapidly becoming the standard for performing hydrogenation reactions in research laboratories."

For more information please visit http://www.thalesnano.com

About ThalesNano Inc.:

ThalesNano Inc. is a technology-intensive company that provides solutions for leading pharmaceutical and biotechnology companies from all over the world. It is specialized in developing and providing microscale flow instruments for chemistry, by exploiting the benefits of combining microfluidics, mezofluidics or nanotechnology with flow chemistry.

The award winning development, H-Cube(R), has been recognized as one of the 100 most technologically significant and innovative new products of 2005 by R&D Magazine is the first in a new wave of continuous-flow hydrogenation reactors.

Thalesnano Nanotechnology Inc

CONTACT: Contact: Dr. Laszlo Urge, CEO, e-mail: sales@thalesnano.com; CarlJones: e-mail: flowchemistry@halesnano.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES